OasisLMS

Retail wearable arrhythmia devices are becoming more frequently used by both arrhythmia patients and by individuals with no antecedent cardiac history. Management approaches to address detected abnormalities or potential abnormalities remain a work in progress. In this session we will engage a broad-based faculty to identify the major concerns and discuss possible best practice solutions.